Enlivex Therapeutics
ENLV
ENLV
2 hedge funds and large institutions have $106K invested in Enlivex Therapeutics in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 6 closing their positions.
Holders
2
Holders Change
-7
Holders Change %
-77.78%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Renaissance Technologies
New York
| $106K | 49,160 | -158,540 | -76% |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| – | – | -37,500 | Closed |
|
3
HighTower Advisors
Chicago,
Illinois
| – | – | -24,000 | Closed |
|
|
OC
4
Oppenheimer & Co
New York
| – | – | -13,100 | Closed |
|
|
TSS
5
Two Sigma Securities
New York
| – | – | -12,748 | Closed |
|
6
UBS Group
Zurich,
Switzerland
| – | – | -6,200 | Closed |
|
|
LTFS
7
Ladenburg Thalmann Financial Services
Miami,
Florida
| $0 | 200 | -800 | -80% |
|
8
Morgan Stanley
New York
| – | – | -713 | Closed |
|